66. IgA nephropathy Clinical trials / Disease details

Clinical trials : 255 / Drugs : 255 - (DrugBank : 79) / Drug target genes : 35 - Drug target pathways : 137

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01237028 (ClinicalTrials.gov)	March 2011	8/11/2010	Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers	Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers	IgA Nephropathy	Drug: Calcitriol	Yonsei University	NULL	Completed	20 Years	70 Years	Both	168	N/A	Korea, Republic of
2	NCT00319761 (ClinicalTrials.gov)	May 2006	27/4/2006	Calcitriol in the Treatment of Immunoglobulin A (IgA) Nephropathy	The Safety and Short-Term Efficacy of Calcitriol in the Treatment of Immunoglobulin A Nephropathy	IGA Nephropathy	Drug: Calcitriol	Chinese University of Hong Kong	NULL	Completed	18 Years	65 Years	Both	10	Phase 4	Hong Kong